- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ASP1517
Total 27 results
-
Astellas Pharma IncFibroGenCompletedChronic Kidney DiseaseJapan
-
Astellas Pharma IncFibroGenCompletedESA-naive Hemodialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma IncFibroGenCompletedPeritoneal Dialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma IncFibroGenCompletedHemodialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma Europe B.V.FibroGenCompletedImpaired Renal Function | Normal Renal FunctionGermany, United Kingdom
-
Astellas Pharma IncFibroGenCompleted
-
Astellas Pharma IncCompletedAnemia in Chronic Kidney Disease Patients Not on DialysisJapan
-
Astellas Pharma Global Development, Inc.FibroGenCompletedHealthy Adult SubjectsGermany
-
Astellas Pharma IncCompletedAnemia | Hemodialysis | Renal ImpairmentJapan
-
Astellas Pharma IncFibroGenCompletedHemodialysis Patients With Renal AnemiaJapan
-
Astellas Pharma IncFibroGenCompleted
-
Astellas Pharma IncActive, not recruiting
-
Astellas Pharma Global Development, Inc.RecruitingChronic Kidney Disease | Renal AnemiaRomania, Spain, Belgium, Germany, Norway, Slovakia, Denmark
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia in Chronic Kidney Disease in Non-dialysis PatientsAustria, Belarus, Bulgaria, Croatia, Czechia, Finland, France, Georgia, Germany, Hungary, Ireland, Israel, Latvia, Montenegro, Netherlands, North Macedonia, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Spain and more
-
Astellas Pharma IncCompletedRenal Anemia Associated With Chronic Renal Failure (CRF)Japan
-
Astellas Pharma IncFibroGenCompleted
-
Astellas Pharma IncCompletedHealthy VolunteersJapan
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Astellas Pharma IncFibroGenCompletedChronic Kidney DiseaseJapan
-
FibroGenAstraZeneca; Astellas Pharma Europe B.V.CompletedAnemia in Incident Dialysis PatientsRussian Federation, Bulgaria, Thailand, United States, Argentina, Chile, Colombia, Korea, Republic of, Latvia, Malaysia, Mexico, Poland, Romania, Taiwan, Ukraine
-
FibroGenAstraZeneca; Astellas Pharma Europe B.V.CompletedCKD AnemiaUnited States, Australia, Thailand, Korea, Republic of, Malaysia, Mexico, Taiwan, New Zealand, Argentina, Chile, Colombia, Hong Kong, Peru, Philippines, Puerto Rico, Singapore
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia in Chronic Kidney Disease in Non-dialysis PatientsSpain, Belarus, Bulgaria, Hungary, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, Belgium, Georgia, Italy, Colombia, Dominican Republic, Estonia, Greece, Guatemala, Panama, Peru, South Africa, Turkey
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia | End Stage Renal Disease (ESRD)Bulgaria, Croatia, Czechia, Germany, Hungary, Poland, Russian Federation, Serbia, Spain, United Kingdom, Belgium, France, Georgia, Italy, Portugal, Romania, Slovakia
-
Astellas Pharma a/sCompletedChronic Kidney Disease Associated AnemiaSweden
-
Astellas Pharma Europe B.V.FibroGenCompletedHepatic Insufficiency | Healthy Subjects | PK of FG-4592Bulgaria
-
Astellas Pharma Europe B.V.FibroGenCompletedHealthy Subjects | Pharmacokinetics of FG-4592Germany
-
Astellas Pharma Europe B.V.FibroGenCompletedHealthy Subjects | PK for FG-4592Germany